Arkolith/Insider Trading/GANX/Form 4

Alder Matthias

Chief Executive Officer, DirectorGain Therapeutics, Inc. (GANX) · full profile →Form 4 · filed Mar 28, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
7
4 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 26, 2024Tax withholding(F)6K$4.06$25K21K
Mar 26, 2024Option exercise(M)825——27K
Mar 26, 2024Option exercise(M)19K——26K
Mar 26, 2024Option exercise(M)637——27K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 26, 2024Option exercise(M)825—$08K
Mar 26, 2024Option exercise(M)19K—$056K
Mar 26, 2024Option exercise(M)637—$06K

Transaction Codes

F
Shares withheld for taxes
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-24-011836) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML